© 2005 by BMJ Publishing Group & British Cardiac Society
EDITORIAL
Myocardial metabolic manipulation: a new therapeutic approach in heart failure?
Department of Cardiology, Western Infirmary, Glasgow, UK
Correspondence to:
Correspondence to:
Professor John J V McMurray
Department of Cardiology, Western Infirmary, Glasgow, G11 6NT, UK; j.mcmurray{at}bio.gla.ac.uk
Myocardial metabolic manipulation using drugs such as trimetazidine may offer a new therapeutic approach to the treatment of heart failure
Abbreviations: ACE, angiotensin converting enzyme; ATP, adenosine triphosphate; FFT, free fatty acids; NYHA, New York Heart Association
Keywords: heart failure; myocardial metabolic manipulation; trimetazidine
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Zerumsky, K., McBride, B. F.
(2006). Ranolazine in the management of chronic stable angina. Am J Health Syst Pharm
63: 2331-2338
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
